Mid Cap Stocks
Plenty of run left in Genetic Signatures
Finfeed Archived May 11, 2020
There has been continual strong news flow from the Genetic Signature Ltd (ASX: GSS), as it received CE-IVD registration for its SARS-CoV-2 Detection Kit, as well as notification from the Therapeutic Goods Administration (TGA) that its EasyScreenTM SARS-CoV-2 Detection Kit has been approved to be listed on the ARTG in Australia.
Investing part 4: Bargain buys in the small to midcap sectors
Finfeed Archived Mar 25, 2020
Should companies have been sold down so drastically, particularly given that for the best part their exploration and research activities were uninterrupted and they didn’t have a disrupted revenue/earnings stream.